Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$13.18 - $19.83 $1.33 Million - $2.01 Million
-101,261 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$9.59 - $50.88 $757,552 - $4.02 Million
-78,994 Reduced 43.82%
101,261 $1.36 Million
Q1 2021

May 14, 2021

BUY
$49.53 - $68.4 $3.19 Million - $4.4 Million
64,344 Added 55.51%
180,255 $9.24 Million
Q4 2020

Feb 02, 2021

BUY
$47.25 - $65.16 $131,780 - $181,731
2,789 Added 2.47%
115,911 $7.18 Million
Q3 2020

Nov 05, 2020

BUY
$46.35 - $61.69 $644,450 - $857,737
13,904 Added 14.01%
113,122 $6.2 Million
Q2 2020

Aug 12, 2020

BUY
$38.58 - $65.07 $329,203 - $555,242
8,533 Added 9.41%
99,218 $5.71 Million
Q1 2020

May 12, 2020

BUY
$32.73 - $50.78 $542,827 - $842,186
16,585 Added 22.38%
90,685 $3.64 Million
Q4 2019

Jan 27, 2020

BUY
$6.81 - $39.55 $190,502 - $1.11 Million
27,974 Added 60.65%
74,100 $2.93 Million
Q3 2019

Oct 31, 2019

BUY
$6.47 - $8.96 $56,515 - $78,265
8,735 Added 23.36%
46,126 $313,000
Q2 2019

Aug 15, 2019

SELL
$8.31 - $14.85 $249,806 - $446,405
-30,061 Reduced 44.57%
37,391 $348,000
Q3 2018

Nov 13, 2018

BUY
$10.49 - $13.72 $48,799 - $63,825
4,652 Added 7.41%
67,452 $853,000
Q3 2017

Nov 15, 2017

BUY
$6.5 - $10.69 $408,200 - $671,332
62,800
62,800 $466,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.